APA

Tyrrell C. J., Denis L., Newling D., Soloway M., Channer K. & Cockshott I. D. (19980407). Casodex 10-200 mg daily, used as monotherapy for the treatment of patients with advanced prostate cancer. An overview of the efficacy, tolerability and pharmacokinetics from three phase II dose-ranging studies. Casodex Study Group. : European urology.

Chicago

Tyrrell C J, Denis L, Newling D, Soloway M, Channer K and Cockshott I D. 19980407. Casodex 10-200 mg daily, used as monotherapy for the treatment of patients with advanced prostate cancer. An overview of the efficacy, tolerability and pharmacokinetics from three phase II dose-ranging studies. Casodex Study Group. : European urology.

Harvard

Tyrrell C. J., Denis L., Newling D., Soloway M., Channer K. and Cockshott I. D. (19980407). Casodex 10-200 mg daily, used as monotherapy for the treatment of patients with advanced prostate cancer. An overview of the efficacy, tolerability and pharmacokinetics from three phase II dose-ranging studies. Casodex Study Group. : European urology.

MLA

Tyrrell C J, Denis L, Newling D, Soloway M, Channer K and Cockshott I D. Casodex 10-200 mg daily, used as monotherapy for the treatment of patients with advanced prostate cancer. An overview of the efficacy, tolerability and pharmacokinetics from three phase II dose-ranging studies. Casodex Study Group. : European urology. 19980407.